149 related articles for article (PubMed ID: 12838958)
1. Proceedings of the 2nd International Conference on Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer. Cambridge, Massachusetts, USA, June 28-29, 2002.
Clin Cancer Res; 2003 Jan; 9(1 Pt 2):443S-532S; quiz i-vi. PubMed ID: 12838958
[No Abstract] [Full Text] [Related]
2. Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer. Proceedings of the 5th International Conference, Cambridge, Massachusetts, USA, June 13-14, 2005.
Clin Cancer Res; 2006 Feb; 12(3 Pt 2):997s-1068s. PubMed ID: 16541524
[No Abstract] [Full Text] [Related]
3. Recent advances and future directions in endocrine manipulation of breast cancer. Proceedings of the Fourth International Conference. July 21-22, 2004. Cambridge, Massachusetts, USA.
Clin Cancer Res; 2005 Jan; 11(2 Pt 2):861s-960s. PubMed ID: 15875333
[No Abstract] [Full Text] [Related]
4. Proceedings of the 3rd International Conference on Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer.
Clin Cancer Res; 2004 Jan; 10(1 Pt 2):327S-409S; quiz i-iv. PubMed ID: 14981797
[No Abstract] [Full Text] [Related]
5. Proceedings of the Fifth International Conference on Recent Advances and Future Directions in Endocrine Therapy for Breast Cancer: conference summary statement.
Come SE; Buzdar AU; Ingle JN; Arteaga CL; Brown M; Dowsett M; Hilsenbeck SG; Kumar R; Johnston SR; Lee AV; Paik S; Pritchard KI; Winer EP; Hart C
Clin Cancer Res; 2006 Feb; 12(3 Pt 2):997s-1000s. PubMed ID: 16467115
[No Abstract] [Full Text] [Related]
6. Proceedings of the Third International Conference on Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer: conference summary statement.
Come SE; Buzdar AU; Arteaga CL; Bissell MJ; Brown MA; Ellis MJ; Goss PE; Green JE; Ingle JN; Lee AV; Medina D; Nicholson RI; Santen RJ; Schiff R; Hart CS
Clin Cancer Res; 2004 Jan; 10(1 Pt 2):327S-330S. PubMed ID: 14734487
[No Abstract] [Full Text] [Related]
7. Second International Conference on Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer: summary consensus statement.
Come SE; Buzdar AU; Arteaga CL; Brodie AM; Davidson NE; Dowsett M; Ingle JN; Johnston SR; Lee AV; Osborne CK; Pritchard KI; Vogel VG; Winer EP; Hart CS
Clin Cancer Res; 2003 Jan; 9(1 Pt 2):443S-6S. PubMed ID: 12538498
[No Abstract] [Full Text] [Related]
8. [Endocrine therapy for postmenopausal breast cancer (role of cycline D1)].
Manikhas AG; Skvortsov VA; Manikhas GM; Raskin GA; Oganesian AS; Shemerovskiĭ AK
Vopr Onkol; 2011; 57(5):641-4. PubMed ID: 22238936
[No Abstract] [Full Text] [Related]
9. Proceedings of the First International Conference on Recent Advances and Future Directions in Endocrine Therapy for Breast Cancer: summary consensus statement.
Buzdar AU; Come SE; Brodie A; Ellis M; Goss PE; Ingle JN; Johnston SR; Lee AV; Osborne CK; Vogel VG; Hart CS
Clin Cancer Res; 2001 Dec; 7(12 Suppl):4335s-4337s; discussion 4411s-4412s. PubMed ID: 11916221
[No Abstract] [Full Text] [Related]
10. Changing concepts of hormone receptor-positive advanced breast cancer therapy.
Chlebowski RT
Clin Breast Cancer; 2013 Jun; 13(3):159-66. PubMed ID: 23228361
[No Abstract] [Full Text] [Related]
11. [Is low-dose tamoxifen an effective therapy for breast carcinoma in situ?].
Ivanova OA; Zhil'tsova EK; Barash NIu; Ivanov VG; Ermachenkova AM
Vopr Onkol; 2011; 57(5):601-3. PubMed ID: 22238929
[No Abstract] [Full Text] [Related]
12. Recent topics in endocrine therapy for hormone-dependent breast cancer: basic research and clinical applications.
Kimijima I
Breast Cancer; 2008; 15(4):253-5. PubMed ID: 18953680
[No Abstract] [Full Text] [Related]
13. Estrogen-dependent tumors. Overview.
Ogata E
Oncology; 1998 Dec; 55 Suppl 1():3-4. PubMed ID: 9935360
[No Abstract] [Full Text] [Related]
14. Equivalence between ovarian suppression and chemotherapy in the adjuvant treatment of endocrine-responsive breast cancer.
Di Leo A; Buyse M
J Clin Oncol; 2002 Apr; 20(7):1954-5. PubMed ID: 11919262
[No Abstract] [Full Text] [Related]
15. Proceedings of the Nordic Ciba Cancer Care Workshop on Advanced Breast Cancer. Stockholm, 18-19 January 1996.
Acta Oncol; 1996; 35 Suppl 5():1-102. PubMed ID: 9156525
[No Abstract] [Full Text] [Related]
16. Proceedings of the 5th International Conference on Neoadjuvant Hormonal Therapy for Prostate Cancer. Cambridge, Massachusetts, March 17-18, 2000.
Mol Urol; 2000; 4(3):89-293; quiz 297-302. PubMed ID: 11184766
[No Abstract] [Full Text] [Related]
17. Aromatase inhibitors for the treatment of breast cancer: is tamoxifen of historical interest only?
Van Poznak CH; Hayes DF
J Natl Cancer Inst; 2006 Sep; 98(18):1261-3. PubMed ID: 16985239
[No Abstract] [Full Text] [Related]
18. [Breast cancer subtypes and their endocrine-metabolic basis; practical aspects].
Bershteĭn LM; Semiglazov VF
Vopr Onkol; 2011; 57(5):559-66. PubMed ID: 22238924
[No Abstract] [Full Text] [Related]
19. Pre-menopausal breast cancer and aromatase inhibitors: Treating a new generation of women.
Freedman OC; Verma S; Clemons MJ
Breast Cancer Res Treat; 2006 Oct; 99(3):241-7. PubMed ID: 16752075
[TBL] [Abstract][Full Text] [Related]
20. [New therapeutical strategies in metastatic hormone-dependent breast cancer].
Vilquin P; Cohen P; Maudelonde T; Tredan O; Treilleux I; Bachelot T; Heudel PE
Bull Cancer; 2015 Apr; 102(4):367-80. PubMed ID: 25799877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
